Enzymatic redesigning of biologically active heparan sulfate

Jinghua Chen, Fikri Y. Avci, Eva M. Muñoz, Lynda M. McDowell, Miao Chen, Lars C. Pedersen, Lijuan Zhang, Robert J. Linhardt, Jian Liu

Research output: Contribution to journalArticlepeer-review

107 Scopus citations

Abstract

Heparan sulfate carries a wide range of biological activities, regulating blood coagulation, cell differentiation, and inflammatory responses. The sulfation patterns of the polysaccharide are essential for the biological activities. In this study, we report an enzymatic method for the sulfation of multmilligram amounts of heparan sulfate with specific functions using immobilized sulfotransferases combined with a 3′-phosphoadenosine 5′-phosphosulfate regeneration system. By selecting appropriate enzymatic modification steps, an inactive precursor has been converted to the heparan sulfate having three distinct biological activities, associated with binding to antithrombin, fibroblast growth factor-2, and herpes simplex virus envelope glycoprotein D. Because the recombinant sulfotransferases are expressed in bacteria, and the method uses a low cost sulfo donor, it can be readily utilized to synthesize large quantities of anticoagulant heparin drug or other biologically active heparan sulfates.

Original languageEnglish
Pages (from-to)42817-42825
Number of pages9
JournalJournal of Biological Chemistry
Volume280
Issue number52
DOIs
StatePublished - 30 Dec 2005
Externally publishedYes

Fingerprint

Dive into the research topics of 'Enzymatic redesigning of biologically active heparan sulfate'. Together they form a unique fingerprint.

Cite this